ADAR1 Capital Management, LLC
InMed Pharmaceuticals Inc. · 10% Owner
ADAR1 Capital Management, LLC is listed in public filings as 10 percent owner. This ADAR1 Capital Management, LLC insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include InMed Pharmaceuticals Inc. (INM), Rallybio Corporation (RLYB), Keros Therapeutics, Inc. (KROS), and Pieris Pharmaceuticals, Inc. (PIRS). Investors use ADAR1 Capital Management, LLC's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
Latest Trades
| Company | Value | Action | Price | Current Price |
|---|---|---|---|---|
| $312k200k shares | BuyMay 19, 2026 | $1.56 | -- | |
| $300k200k shares | BuyMay 19, 2026 | $1.50 | -- | |
| $2.8k200 shares | BuyMay 19, 2026 | $13.80 | -- | |
| $140k10k shares | BuyMay 19, 2026 | $13.98 | -- | |
| $110k68.6k shares | BuyMay 19, 2026 | $1.60 | -- |